| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tubulin binding | MTUS1 BCAS3 KIF19 GOLGA6C GOLGA6D GOLGA6B DLEC1 GOLGA6A GNAS MAPRE2 VBP1 | 1.56e-06 | 428 | 83 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 1.57e-06 | 21 | 83 | 4 | GO:0061676 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TMEM67 PTPN3 MYO3A MTUS1 BCAS3 CAMK2B MYO3B KIF19 GOLGA6C GOLGA6D GOLGA6B DLEC1 GOLGA6A GNAS MAPRE2 VBP1 | 1.00e-05 | 1099 | 83 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | dihydrofolic acid binding | 5.11e-05 | 3 | 83 | 2 | GO:0051871 | |
| GeneOntologyMolecularFunction | dihydrofolate reductase activity | 5.11e-05 | 3 | 83 | 2 | GO:0004146 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 6.40e-05 | 19 | 83 | 3 | GO:1990825 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 1.02e-04 | 4 | 83 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.33e-04 | 118 | 83 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.96e-04 | 308 | 83 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | syntaxin binding | 4.75e-04 | 87 | 83 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 4.86e-04 | 37 | 83 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 9.16e-04 | 11 | 83 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 2.23e-03 | 17 | 83 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | IFIH1 ATP8B4 NUDT14 DNAH12 RRAGA KIF19 GNA12 GNAS DNM1P34 FANCM | 2.47e-03 | 839 | 83 | 10 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | IFIH1 ATP8B4 NUDT14 DNAH12 RRAGA KIF19 GNA12 GNAS DNM1P34 FANCM | 2.49e-03 | 840 | 83 | 10 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | IFIH1 ATP8B4 NUDT14 DNAH12 RRAGA KIF19 GNA12 GNAS DNM1P34 FANCM | 2.49e-03 | 840 | 83 | 10 | GO:0016818 |
| GeneOntologyMolecularFunction | SNARE binding | 2.50e-03 | 136 | 83 | 4 | GO:0000149 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 2.50e-03 | 18 | 83 | 2 | GO:0016646 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.50e-03 | 18 | 83 | 2 | GO:0008569 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 8.03e-08 | 28 | 82 | 5 | GO:0090306 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 3.46e-07 | 37 | 82 | 5 | GO:0000212 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 6.80e-07 | 18 | 82 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 8.59e-07 | 19 | 82 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 1.94e-06 | 23 | 82 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 2.32e-06 | 24 | 82 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | Golgi localization | 3.80e-06 | 27 | 82 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 4.42e-06 | 28 | 82 | 4 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 4.42e-06 | 28 | 82 | 4 | GO:0048313 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 5.61e-06 | 112 | 82 | 6 | GO:0010507 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 9.83e-06 | 34 | 82 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 1.24e-05 | 36 | 82 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.39e-05 | 77 | 82 | 5 | GO:0051289 | |
| GeneOntologyBiologicalProcess | response to host | 1.56e-05 | 2 | 82 | 2 | GO:0075136 | |
| GeneOntologyBiologicalProcess | response to host defenses | 1.56e-05 | 2 | 82 | 2 | GO:0052200 | |
| GeneOntologyBiologicalProcess | response to defenses of other organism | 1.56e-05 | 2 | 82 | 2 | GO:0052173 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 1.90e-05 | 40 | 82 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | TMEM67 MYO3A TOX NCKAP1 CAMK2B MYO3B GOLGA6C GOLGA6D GOLGA6B GOLGA6A | 2.59e-05 | 494 | 82 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TMEM67 MYO3A TOX HECW1 NCKAP1 CAMK2B FAT3 MYO3B GOLGA6C GOLGA6D AKT1 GOLGA6B GOLGA6A | 2.76e-05 | 846 | 82 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of nitric-oxide synthase activity | 3.27e-05 | 16 | 82 | 3 | GO:0051000 | |
| GeneOntologyBiologicalProcess | spindle assembly | 3.32e-05 | 153 | 82 | 6 | GO:0051225 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TMEM67 MYO3A TOX HECW1 NCKAP1 CAMK2B FAT3 MYO3B GOLGA6C GOLGA6D AKT1 GOLGA6B GOLGA6A | 3.39e-05 | 863 | 82 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | response to methotrexate | 4.67e-05 | 3 | 82 | 2 | GO:0031427 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 4.79e-05 | 240 | 82 | 7 | GO:0140013 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 5.16e-05 | 101 | 82 | 5 | GO:0002028 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 5.61e-05 | 168 | 82 | 6 | GO:0031109 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 6.50e-05 | 106 | 82 | 5 | GO:0032091 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 7.59e-05 | 350 | 82 | 8 | GO:0051321 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 7.81e-05 | 57 | 82 | 4 | GO:0007020 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 8.80e-05 | 113 | 82 | 5 | GO:0051262 | |
| GeneOntologyBiologicalProcess | dihydrofolate metabolic process | 9.32e-05 | 4 | 82 | 2 | GO:0046452 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 9.58e-05 | 268 | 82 | 7 | GO:1903046 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 1.26e-04 | 122 | 82 | 5 | GO:0045132 | |
| GeneOntologyBiologicalProcess | diol biosynthetic process | 1.31e-04 | 25 | 82 | 3 | GO:0034312 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 1.63e-04 | 204 | 82 | 6 | GO:1903008 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 1.65e-04 | 69 | 82 | 4 | GO:0010559 | |
| GeneOntologyBiologicalProcess | positive regulation of monooxygenase activity | 1.65e-04 | 27 | 82 | 3 | GO:0032770 | |
| GeneOntologyBiologicalProcess | regulation of nitric-oxide synthase activity | 2.05e-04 | 29 | 82 | 3 | GO:0050999 | |
| GeneOntologyBiologicalProcess | spindle organization | 2.70e-04 | 224 | 82 | 6 | GO:0007051 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 2.92e-04 | 80 | 82 | 4 | GO:1903018 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 2.97e-04 | 228 | 82 | 6 | GO:0043393 | |
| GeneOntologyBiologicalProcess | diol metabolic process | 3.32e-04 | 34 | 82 | 3 | GO:0034311 | |
| GeneOntologyBiologicalProcess | regulation of removal of superoxide radicals | 4.30e-04 | 8 | 82 | 2 | GO:2000121 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate biosynthetic process | 4.30e-04 | 8 | 82 | 2 | GO:0046654 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 4.97e-04 | 92 | 82 | 4 | GO:0090307 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 4.98e-04 | 164 | 82 | 5 | GO:0007098 | |
| GeneOntologyBiologicalProcess | neuron projection development | MYO3A TOX HECW1 NCKAP1 CAMK2B FAT3 DHFR MYO3B DHFR2 GOLGA6C GOLGA6D AKT1 GOLGA6B GOLGA6A | 5.04e-04 | 1285 | 82 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | tetrahydrobiopterin biosynthetic process | 5.52e-04 | 9 | 82 | 2 | GO:0006729 | |
| GeneOntologyBiologicalProcess | glycine biosynthetic process | 5.52e-04 | 9 | 82 | 2 | GO:0006545 | |
| GeneOntologyBiologicalProcess | Golgi organization | 5.56e-04 | 168 | 82 | 5 | GO:0007030 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TMEM67 CCNB2 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPAG17 MAPRE2 | 5.59e-04 | 720 | 82 | 10 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of superoxide metabolic process | 5.79e-04 | 41 | 82 | 3 | GO:0090322 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 5.86e-04 | 170 | 82 | 5 | GO:0051100 | |
| GeneOntologyBiologicalProcess | neuron development | TMEM67 MYO3A TOX HECW1 NCKAP1 CAMK2B FAT3 DHFR MYO3B DHFR2 GOLGA6C GOLGA6D AKT1 GOLGA6B GOLGA6A | 5.87e-04 | 1463 | 82 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | tetrahydrobiopterin metabolic process | 6.88e-04 | 10 | 82 | 2 | GO:0046146 | |
| GeneOntologyBiologicalProcess | regulation of monooxygenase activity | 7.13e-04 | 44 | 82 | 3 | GO:0032768 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 7.17e-04 | 612 | 82 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 7.40e-04 | 179 | 82 | 5 | GO:0031023 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 7.98e-04 | 275 | 82 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 8.13e-04 | 46 | 82 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | regulation of response to oxidative stress | 8.66e-04 | 47 | 82 | 3 | GO:1902882 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TMEM67 MYO3A APPL2 TOX NCKAP1 CAMK2B MYO3B GOLGA6C GOLGA6D UFL1 GOLGA6B GOLGA6A DDHD2 MAPRE2 | 9.19e-04 | 1366 | 82 | 14 | GO:0051130 |
| GeneOntologyBiologicalProcess | microtubule-based process | TMEM67 DNAH12 CCNB2 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPAG17 MAPRE2 VBP1 | 9.34e-04 | 1058 | 82 | 12 | GO:0007017 |
| GeneOntologyBiologicalProcess | folic acid-containing compound biosynthetic process | 1.00e-03 | 12 | 82 | 2 | GO:0009396 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | 1.07e-03 | 400 | 82 | 7 | GO:0010506 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.11e-03 | 114 | 82 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 1.15e-03 | 115 | 82 | 4 | GO:0018107 | |
| GeneOntologyBiologicalProcess | protein complex oligomerization | 1.17e-03 | 296 | 82 | 6 | GO:0051259 | |
| GeneOntologyBiologicalProcess | regulation of response to reactive oxygen species | 1.18e-03 | 13 | 82 | 2 | GO:1901031 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.22e-03 | 117 | 82 | 4 | GO:0046785 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | PTPN3 CROT PNPLA6 ASAH1 BCAS3 RRAGA GOLGA6C GOLGA6D AKT1 UFL1 GOLGA6B GOLGA6A DDHD2 | 1.28e-03 | 1253 | 82 | 13 | GO:0044248 |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.38e-03 | 418 | 82 | 7 | GO:0009895 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast migration | 1.44e-03 | 56 | 82 | 3 | GO:0010762 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 1.47e-03 | 123 | 82 | 4 | GO:0120034 | |
| GeneOntologyBiologicalProcess | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.49e-03 | 424 | 82 | 7 | GO:0043161 | |
| GeneOntologyBiologicalProcess | cell cycle process | TMEM67 APPL2 CCNB2 CAMK2B GOLGA6C GOLGA6D AKT1 UFL1 GOLGA6B GOLGA6A STOX1 FANCM MAPRE2 ANAPC4 | 1.53e-03 | 1441 | 82 | 14 | GO:0022402 |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.56e-03 | 125 | 82 | 4 | GO:0018210 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal protein catabolic process | 1.60e-03 | 213 | 82 | 5 | GO:0061136 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate interconversion | 1.81e-03 | 16 | 82 | 2 | GO:0035999 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin E stimulus | 1.81e-03 | 16 | 82 | 2 | GO:0071380 | |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | 1.86e-03 | 567 | 82 | 8 | GO:0010498 | |
| GeneOntologyCellularComponent | microtubule | DNAH12 MTUS1 BCAS3 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPAG17 MAPRE2 | 6.46e-06 | 533 | 81 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | Golgi cis cisterna | 7.86e-06 | 33 | 81 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYO3A DNAH12 NCKAP1 MTUS1 BCAS3 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPAG17 MAPRE2 | 3.94e-05 | 899 | 81 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | anchoring collagen complex | 4.44e-05 | 3 | 81 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.86e-05 | 110 | 81 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 2.20e-04 | 6 | 81 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | cis-Golgi network | 3.34e-04 | 85 | 81 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | spindle | 4.77e-04 | 471 | 81 | 8 | GO:0005819 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 4.90e-04 | 94 | 81 | 4 | GO:0032580 | |
| GeneOntologyCellularComponent | GTPase complex | 5.37e-04 | 41 | 81 | 3 | GO:1905360 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYO3A DNAH12 NCKAP1 MTUS1 BCAS3 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPAG17 MAPRE2 | 5.72e-04 | 1179 | 81 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYO3A DNAH12 NCKAP1 MTUS1 BCAS3 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPAG17 MAPRE2 | 6.10e-04 | 1187 | 81 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | axoneme | 1.26e-03 | 207 | 81 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.29e-03 | 208 | 81 | 5 | GO:0097014 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.75e-03 | 223 | 81 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.88e-03 | 135 | 81 | 4 | GO:0031985 | |
| GeneOntologyCellularComponent | filopodium tip | 2.69e-03 | 20 | 81 | 2 | GO:0032433 | |
| GeneOntologyCellularComponent | coated vesicle | 2.75e-03 | 360 | 81 | 6 | GO:0030135 | |
| GeneOntologyCellularComponent | stereocilium tip | 3.26e-03 | 22 | 81 | 2 | GO:0032426 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 3.46e-03 | 78 | 81 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | brush border membrane | 4.12e-03 | 83 | 81 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.20e-03 | 25 | 81 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | Golgi stack | 4.41e-03 | 171 | 81 | 4 | GO:0005795 | |
| MousePheno | increased alveolar macrophage number | 3.86e-07 | 14 | 64 | 4 | MP:0014228 | |
| MousePheno | abnormal actin cytoskeleton morphology | 4.31e-07 | 34 | 64 | 5 | MP:0020849 | |
| MousePheno | abnormal alveolar macrophage number | 5.25e-07 | 15 | 64 | 4 | MP:0014227 | |
| MousePheno | abnormal sperm nucleus morphology | 1.05e-06 | 74 | 64 | 6 | MP:0009232 | |
| MousePheno | abnormal cell cytoskeleton morphology | 1.14e-06 | 75 | 64 | 6 | MP:0020378 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 2.04e-06 | 46 | 64 | 5 | MP:0020850 | |
| MousePheno | abnormal Golgi vesicle transport | 2.75e-06 | 22 | 64 | 4 | MP:0030949 | |
| MousePheno | ataxia | AARS1 CAMK2B PSMA5 GOLGA6C GOLGA6D GOLGA6B GOLGA6A GNAS CAMTA1 | 3.15e-06 | 266 | 64 | 9 | MP:0001393 |
| MousePheno | abnormal proacrosomal vesicle fusion | 3.96e-06 | 24 | 64 | 4 | MP:0031355 | |
| MousePheno | abnormal spermatid morphology | 6.22e-06 | 217 | 64 | 8 | MP:0006380 | |
| MousePheno | abnormal alveolar macrophage morphology | 6.48e-06 | 27 | 64 | 4 | MP:0008245 | |
| MousePheno | immotile sperm | 7.10e-06 | 59 | 64 | 5 | MP:0020869 | |
| MousePheno | absent sperm mitochondrial sheath | 7.53e-06 | 28 | 64 | 4 | MP:0009833 | |
| MousePheno | abnormal acrosome morphology | 7.78e-06 | 159 | 64 | 7 | MP:0008898 | |
| MousePheno | absent acrosome | 1.30e-05 | 32 | 64 | 4 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 1.48e-05 | 33 | 64 | 4 | MP:0011743 | |
| MousePheno | globozoospermia | 2.17e-05 | 74 | 64 | 5 | MP:0002686 | |
| MousePheno | abnormal sperm head morphology | 2.38e-05 | 261 | 64 | 8 | MP:0009230 | |
| MousePheno | liver fibrosis | 2.63e-05 | 77 | 64 | 5 | MP:0003333 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 3.17e-05 | 80 | 64 | 5 | MP:0010898 | |
| MousePheno | abnormal motile cilium morphology | TMEM67 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B DLEC1 GOLGA6A SPAG17 | 4.40e-05 | 370 | 64 | 9 | MP:0013206 |
| MousePheno | oligozoospermia | DNAH17 GOLGA6C GOLGA6D AKT1 GOLGA6B KPNA6 DLEC1 GOLGA6A SPAG17 | 5.87e-05 | 384 | 64 | 9 | MP:0002687 |
| MousePheno | abnormal acrosome assembly | 6.21e-05 | 92 | 64 | 5 | MP:0031354 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 7.24e-05 | 95 | 64 | 5 | MP:0009832 | |
| MousePheno | pulmonary fibrosis | 8.50e-05 | 51 | 64 | 4 | MP:0006050 | |
| MousePheno | abnormal spermiogenesis | 1.01e-04 | 237 | 64 | 7 | MP:0001932 | |
| MousePheno | abnormal motor coordination/balance | AARS1 SYN3 HECW1 CAMK2B PSMA5 GOLGA6C GOLGA6D GOLGA6B GOLGA6A GNAS DDHD2 CAMTA1 SPAG17 | 1.35e-04 | 873 | 64 | 13 | MP:0001516 |
| MousePheno | abnormal surfactant physiology | 1.41e-04 | 58 | 64 | 4 | MP:0004782 | |
| MousePheno | abnormal cilium morphology | TMEM67 DNAH17 KIF19 GOLGA6C GOLGA6D GOLGA6B DLEC1 GOLGA6A SPAG17 | 1.47e-04 | 433 | 64 | 9 | MP:0013202 |
| MousePheno | postnatal growth retardation | IFIH1 TMEM67 ASAH1 CAMK2B KIF19 GOLGA6C GOLGA6D AKT1 GOLGA6B KPNA6 GOLGA6A GNAS NFAT5 | 1.48e-04 | 881 | 64 | 13 | MP:0001732 |
| MousePheno | abnormal postnatal growth | IFIH1 TMEM67 ASAH1 CAMK2B KIF19 GOLGA6C GOLGA6D AKT1 GOLGA6B KPNA6 GOLGA6A GNAS NFAT5 | 1.97e-04 | 907 | 64 | 13 | MP:0001731 |
| MousePheno | abnormal lung epithelium morphology | 2.02e-04 | 118 | 64 | 5 | MP:0006382 | |
| MousePheno | abnormal type II pneumocyte morphology | 2.47e-04 | 67 | 64 | 4 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 2.47e-04 | 67 | 64 | 4 | MP:0000880 | |
| MousePheno | abnormal Purkinje cell number | 2.76e-04 | 69 | 64 | 4 | MP:0000878 | |
| MousePheno | abnormal pulmonary acinus morphology | 3.06e-04 | 284 | 64 | 7 | MP:0010911 | |
| MousePheno | slow postnatal weight gain | 3.42e-04 | 205 | 64 | 6 | MP:0008489 | |
| MousePheno | abnormal sperm flagellum morphology | 3.85e-04 | 295 | 64 | 7 | MP:0008892 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 3.93e-04 | 296 | 64 | 7 | MP:0010899 | |
| MousePheno | abnormal locomotor coordination | AARS1 ASAH1 CAMK2B PSMA5 GOLGA6C GOLGA6D GOLGA6B GOLGA6A GNAS DDHD2 CAMTA1 | 4.11e-04 | 726 | 64 | 11 | MP:0003312 |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 4.21e-04 | 77 | 64 | 4 | MP:0002273 | |
| MousePheno | abnormal cerebellar cortex morphology | 4.26e-04 | 300 | 64 | 7 | MP:0004097 | |
| MousePheno | abnormal sperm number | DNAH17 GOLGA6C GOLGA6D AKT1 GOLGA6B KPNA6 DLEC1 GOLGA6A SPAG17 FANCM | 5.00e-04 | 624 | 64 | 10 | MP:0002673 |
| MousePheno | abnormal sperm midpiece morphology | 5.06e-04 | 144 | 64 | 5 | MP:0009831 | |
| MousePheno | teratozoospermia | 5.21e-04 | 408 | 64 | 8 | MP:0005578 | |
| MousePheno | decreased male germ cell number | DNAH17 GOLGA6C GOLGA6D AKT1 GOLGA6B KPNA6 DLEC1 GOLGA6A SPAG17 FANCM | 6.10e-04 | 640 | 64 | 10 | MP:0004901 |
| MousePheno | abnormal respiratory epithelium morphology | 7.03e-04 | 235 | 64 | 6 | MP:0010942 | |
| MousePheno | decreased granulocyte monocyte progenitor cell number | 7.28e-04 | 9 | 64 | 2 | MP:0013697 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 7.60e-04 | 90 | 64 | 4 | MP:0010901 | |
| MousePheno | abnormal hepatocyte morphology | 9.63e-04 | 166 | 64 | 5 | MP:0000607 | |
| MousePheno | decreased germ cell number | DNAH17 GOLGA6C GOLGA6D AKT1 GOLGA6B KPNA6 DLEC1 GOLGA6A SPAG17 FANCM | 1.05e-03 | 687 | 64 | 10 | MP:0002209 |
| MousePheno | abnormal pulmonary alveolus morphology | 1.08e-03 | 255 | 64 | 6 | MP:0002270 | |
| MousePheno | decreased sperm progressive motility | 1.13e-03 | 100 | 64 | 4 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 1.17e-03 | 101 | 64 | 4 | MP:0020450 | |
| MousePheno | increased nucleated erythrocyte cell number | 1.29e-03 | 47 | 64 | 3 | MP:0009395 | |
| MousePheno | asthenozoospermia | 1.29e-03 | 362 | 64 | 7 | MP:0002675 | |
| MousePheno | abnormal folic acid level | 1.32e-03 | 12 | 64 | 2 | MP:0011230 | |
| MousePheno | abnormal nucleated erythrocyte cell number | 1.45e-03 | 49 | 64 | 3 | MP:0012397 | |
| MousePheno | abnormal macrophage cell number | 1.67e-03 | 278 | 64 | 6 | MP:0020202 | |
| MousePheno | abnormal granulocyte monocyte progenitor cell number | 1.81e-03 | 14 | 64 | 2 | MP:0013695 | |
| MousePheno | abnormal DNA methylation | 1.82e-03 | 53 | 64 | 3 | MP:0008877 | |
| MousePheno | abnormal cerebellum morphology | 1.94e-03 | 389 | 64 | 7 | MP:0000849 | |
| MousePheno | abnormal granulocyte monocyte progenitor cell morphology | 2.08e-03 | 15 | 64 | 2 | MP:0013694 | |
| MousePheno | abnormal chorionic plate morphology | 2.08e-03 | 15 | 64 | 2 | MP:0004560 | |
| Domain | GOLGA2L5 | 7.82e-07 | 18 | 77 | 4 | PF15070 | |
| Domain | Golgin_A | 7.82e-07 | 18 | 77 | 4 | IPR024858 | |
| Domain | DHFR_dom | 1.68e-05 | 2 | 77 | 2 | IPR001796 | |
| Domain | NPY4_rcpt | 1.68e-05 | 2 | 77 | 2 | IPR001933 | |
| Domain | DHFR_2 | 1.68e-05 | 2 | 77 | 2 | PS51330 | |
| Domain | - | 1.68e-05 | 2 | 77 | 2 | 3.40.430.10 | |
| Domain | DHFR_1 | 1.68e-05 | 2 | 77 | 2 | PF00186 | |
| Domain | DHFR-like_dom | 1.68e-05 | 2 | 77 | 2 | IPR024072 | |
| Domain | DHFR_1 | 1.68e-05 | 2 | 77 | 2 | PS00075 | |
| Domain | DHFR | 1.68e-05 | 2 | 77 | 2 | IPR012259 | |
| Domain | ResIII | 4.62e-04 | 8 | 77 | 2 | PF04851 | |
| Domain | Helicase/UvrB_N | 4.62e-04 | 8 | 77 | 2 | IPR006935 | |
| Domain | NPY_rcpt | 5.93e-04 | 9 | 77 | 2 | IPR000611 | |
| Domain | VWA | 1.60e-03 | 56 | 77 | 3 | PF00092 | |
| Domain | Laminin_G | 1.77e-03 | 58 | 77 | 3 | IPR001791 | |
| Domain | G-alpha | 1.94e-03 | 16 | 77 | 2 | PF00503 | |
| Domain | GproteinA_insert | 1.94e-03 | 16 | 77 | 2 | IPR011025 | |
| Domain | - | 1.94e-03 | 16 | 77 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 1.94e-03 | 16 | 77 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 2.19e-03 | 17 | 77 | 2 | IPR001019 | |
| Domain | P-loop_NTPase | IFIH1 MYO3A DNAH12 RRAGA MYO3B KIF19 GNA12 GNAS CAMTA1 FANCM | 2.46e-03 | 848 | 77 | 10 | IPR027417 |
| Domain | IQ | 3.15e-03 | 71 | 77 | 3 | PF00612 | |
| Domain | - | 3.54e-03 | 74 | 77 | 3 | 3.40.50.410 | |
| Domain | Pentatricopeptide_repeat | 4.01e-03 | 23 | 77 | 2 | IPR002885 | |
| Domain | TSPN | 4.01e-03 | 23 | 77 | 2 | SM00210 | |
| Domain | IQ | 4.56e-03 | 81 | 77 | 3 | SM00015 | |
| Domain | VWFA | 4.72e-03 | 82 | 77 | 3 | PS50234 | |
| Domain | VWA | 5.05e-03 | 84 | 77 | 3 | SM00327 | |
| Domain | IQ_motif_EF-hand-BS | 6.12e-03 | 90 | 77 | 3 | IPR000048 | |
| Domain | IQ | 6.70e-03 | 93 | 77 | 3 | PS50096 | |
| Domain | - | 7.11e-03 | 95 | 77 | 3 | 2.60.120.200 | |
| Domain | TIG | 7.22e-03 | 31 | 77 | 2 | PF01833 | |
| Domain | IPT | 7.68e-03 | 32 | 77 | 2 | IPR002909 | |
| Domain | VWF_A | 7.96e-03 | 99 | 77 | 3 | IPR002035 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 3.41e-06 | 23 | 65 | 4 | MM14620 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 2.12e-08 | 13 | 83 | 4 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 2.12e-08 | 13 | 83 | 4 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 2.12e-08 | 13 | 83 | 4 | 32873390 | |
| Pubmed | 2.12e-08 | 13 | 83 | 4 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 2.12e-08 | 13 | 83 | 4 | 29128360 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 2.12e-08 | 13 | 83 | 4 | 28028212 | |
| Pubmed | A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. | 2.81e-08 | 37 | 83 | 5 | 21725307 | |
| Pubmed | 2.96e-08 | 14 | 83 | 4 | 30630895 | ||
| Pubmed | 2.96e-08 | 14 | 83 | 4 | 37831422 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 2.96e-08 | 14 | 83 | 4 | 27226319 | |
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 2.96e-08 | 14 | 83 | 4 | 33543287 | |
| Pubmed | 3.23e-08 | 38 | 83 | 5 | 26595272 | ||
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 4.03e-08 | 15 | 83 | 4 | 26165940 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 4.03e-08 | 15 | 83 | 4 | 17204322 | |
| Pubmed | 4.03e-08 | 15 | 83 | 4 | 16413118 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 4.03e-08 | 15 | 83 | 4 | 23185636 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 4.03e-08 | 15 | 83 | 4 | 17046993 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 4.03e-08 | 15 | 83 | 4 | 17189423 | |
| Pubmed | 4.03e-08 | 15 | 83 | 4 | 26083584 | ||
| Pubmed | 4.03e-08 | 15 | 83 | 4 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 4.03e-08 | 15 | 83 | 4 | 28509431 | |
| Pubmed | 4.80e-08 | 41 | 83 | 5 | 30022023 | ||
| Pubmed | 5.37e-08 | 16 | 83 | 4 | 16399995 | ||
| Pubmed | 5.37e-08 | 16 | 83 | 4 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 5.37e-08 | 16 | 83 | 4 | 21640725 | |
| Pubmed | 5.37e-08 | 16 | 83 | 4 | 16336229 | ||
| Pubmed | 5.37e-08 | 16 | 83 | 4 | 18166528 | ||
| Pubmed | BCAS2 regulates oocyte meiotic prophase I by participating in mRNA alternative splicing. | 6.92e-08 | 44 | 83 | 5 | 38085152 | |
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 7.01e-08 | 17 | 83 | 4 | 14718562 | |
| Pubmed | 7.01e-08 | 17 | 83 | 4 | 28717168 | ||
| Pubmed | 7.01e-08 | 17 | 83 | 4 | 27655914 | ||
| Pubmed | 7.01e-08 | 17 | 83 | 4 | 14728599 | ||
| Pubmed | 7.01e-08 | 17 | 83 | 4 | 20004763 | ||
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 21147753 | ||
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 24227724 | ||
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 22718342 | ||
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 20943658 | ||
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 15800058 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 8.99e-08 | 18 | 83 | 4 | 20230794 | |
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 8.99e-08 | 18 | 83 | 4 | 24367100 | |
| Pubmed | 8.99e-08 | 18 | 83 | 4 | 25208654 | ||
| Pubmed | 1.14e-07 | 19 | 83 | 4 | 23444373 | ||
| Pubmed | 1.14e-07 | 19 | 83 | 4 | 12646573 | ||
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 1.14e-07 | 19 | 83 | 4 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 1.14e-07 | 19 | 83 | 4 | 17664336 | |
| Pubmed | 1.14e-07 | 19 | 83 | 4 | 17724343 | ||
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 1.14e-07 | 19 | 83 | 4 | 34042944 | |
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 1.14e-07 | 19 | 83 | 4 | 34255394 | |
| Pubmed | 1.14e-07 | 19 | 83 | 4 | 15452145 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 1.14e-07 | 19 | 83 | 4 | 14622145 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 1.14e-07 | 19 | 83 | 4 | 38048369 | |
| Pubmed | 1.14e-07 | 19 | 83 | 4 | 22841714 | ||
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 1.14e-07 | 19 | 83 | 4 | 17003038 | |
| Pubmed | 1.42e-07 | 20 | 83 | 4 | 23918928 | ||
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 1.42e-07 | 20 | 83 | 4 | 21300694 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 1.42e-07 | 20 | 83 | 4 | 20368623 | |
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 1.42e-07 | 20 | 83 | 4 | 31949138 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 1.42e-07 | 20 | 83 | 4 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 1.42e-07 | 20 | 83 | 4 | 34128978 | |
| Pubmed | 1.42e-07 | 20 | 83 | 4 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 1.42e-07 | 20 | 83 | 4 | 29437892 | |
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 1.75e-07 | 21 | 83 | 4 | 27118846 | |
| Pubmed | 1.75e-07 | 21 | 83 | 4 | 21645620 | ||
| Pubmed | 1.75e-07 | 21 | 83 | 4 | 36292593 | ||
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 1.75e-07 | 21 | 83 | 4 | 19061864 | |
| Pubmed | 1.75e-07 | 21 | 83 | 4 | 15229288 | ||
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 1.75e-07 | 21 | 83 | 4 | 22216013 | |
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 1.75e-07 | 21 | 83 | 4 | 20003423 | |
| Pubmed | 1.75e-07 | 21 | 83 | 4 | 23386608 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 2.13e-07 | 22 | 83 | 4 | 36656123 | |
| Pubmed | 2.13e-07 | 22 | 83 | 4 | 34897463 | ||
| Pubmed | Analysis of the DNA sequence and duplication history of human chromosome 15. | 2.38e-07 | 56 | 83 | 5 | 16572171 | |
| Pubmed | 2.58e-07 | 23 | 83 | 4 | 25636444 | ||
| Pubmed | 2.58e-07 | 23 | 83 | 4 | 37848288 | ||
| Pubmed | 2.58e-07 | 23 | 83 | 4 | 18662990 | ||
| Pubmed | Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. | 2.58e-07 | 23 | 83 | 4 | 21111240 | |
| Pubmed | 2.58e-07 | 23 | 83 | 4 | 18001291 | ||
| Pubmed | Pofut1 is required for the proper localization of the Notch receptor during mouse development. | 2.58e-07 | 23 | 83 | 4 | 18547789 | |
| Pubmed | 3.09e-07 | 24 | 83 | 4 | 38814743 | ||
| Pubmed | 3.09e-07 | 24 | 83 | 4 | 26060116 | ||
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 3.09e-07 | 24 | 83 | 4 | 18434600 | |
| Pubmed | 3.09e-07 | 24 | 83 | 4 | 21187406 | ||
| Pubmed | 3.09e-07 | 24 | 83 | 4 | 24161848 | ||
| Pubmed | The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. | 3.09e-07 | 24 | 83 | 4 | 20223754 | |
| Pubmed | Dual role for CXCL12 signaling in semilunar valve development. | 3.09e-07 | 24 | 83 | 4 | 34433040 | |
| Pubmed | Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. | 3.09e-07 | 24 | 83 | 4 | 22364862 | |
| Pubmed | 3.67e-07 | 25 | 83 | 4 | 26582200 | ||
| Pubmed | Nubp1 is required for lung branching morphogenesis and distal progenitor cell survival in mice. | 3.67e-07 | 25 | 83 | 4 | 23028652 | |
| Pubmed | Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. | 3.67e-07 | 25 | 83 | 4 | 15078902 | |
| Pubmed | 3.67e-07 | 25 | 83 | 4 | 26143639 | ||
| Pubmed | Gestational stress induces the unfolded protein response, resulting in heart defects. | 3.67e-07 | 25 | 83 | 4 | 27436040 | |
| Pubmed | 3.67e-07 | 25 | 83 | 4 | 29587143 | ||
| Pubmed | 3.67e-07 | 25 | 83 | 4 | 27471260 | ||
| Pubmed | 3.67e-07 | 25 | 83 | 4 | 24161523 | ||
| Pubmed | CFP1 Regulates Histone H3K4 Trimethylation and Developmental Potential in Mouse Oocytes. | 3.67e-07 | 25 | 83 | 4 | 28768200 | |
| Pubmed | 4.33e-07 | 26 | 83 | 4 | 22806269 | ||
| Pubmed | Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. | 4.33e-07 | 26 | 83 | 4 | 24384391 | |
| Pubmed | 4.33e-07 | 26 | 83 | 4 | 19474315 | ||
| Pubmed | Mouse oocytes develop in cysts with the help of nurse cells. | 4.33e-07 | 26 | 83 | 4 | 35623357 | |
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 4.33e-07 | 26 | 83 | 4 | 31655624 | |
| Interaction | CLRN3 interactions | 1.37e-07 | 13 | 77 | 4 | int:CLRN3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 3.00e-06 | 122 | 83 | 5 | chr15q24 | |
| Cytoband | 15q24.2 | 2.72e-05 | 32 | 83 | 3 | 15q24.2 | |
| Cytoband | 15q24.1 | 1.74e-03 | 34 | 83 | 2 | 15q24.1 | |
| Cytoband | 8p22 | 2.41e-03 | 40 | 83 | 2 | 8p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q23 | 2.59e-03 | 150 | 83 | 3 | chr12q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p22 | 3.31e-03 | 47 | 83 | 2 | chr8p22 | |
| GeneFamily | Myosins, class III|Deafness associated genes | 8.43e-06 | 2 | 53 | 2 | 1099 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 4.56e-04 | 11 | 53 | 2 | 1168 | |
| GeneFamily | Dyneins, axonemal | 1.11e-03 | 17 | 53 | 2 | 536 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | PLSCR4 TMEM67 CROT MTUS1 ASAH1 COL14A1 GNAS DDHD2 PCDH18 PAPOLG | 7.41e-06 | 542 | 82 | 10 | M19529 |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-06 | 194 | 82 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.63e-06 | 195 | 82 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.63e-06 | 195 | 82 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 165 | 82 | 5 | 6e8370b8e747d8ef44a2413a993291a3cd83a77c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 169 | 82 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 171 | 82 | 5 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 173 | 82 | 5 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-05 | 174 | 82 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-05 | 178 | 82 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 1.95e-05 | 178 | 82 | 5 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-05 | 180 | 82 | 5 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-05 | 181 | 82 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 182 | 82 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.35e-05 | 185 | 82 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.41e-05 | 186 | 82 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.48e-05 | 187 | 82 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-05 | 188 | 82 | 5 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.67e-05 | 190 | 82 | 5 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.88e-05 | 193 | 82 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 2.88e-05 | 193 | 82 | 5 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 194 | 82 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-05 | 195 | 82 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.10e-05 | 196 | 82 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 82 | 5 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.18e-05 | 197 | 82 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 3.25e-05 | 198 | 82 | 5 | 3d76393e72eed59b4dd16130ef5dd1d331ba5711 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 3.41e-05 | 200 | 82 | 5 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 200 | 82 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.10e-05 | 104 | 82 | 4 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.23e-04 | 138 | 82 | 4 | e1e936ff4080bda2810c5fd1154a706359f377a5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 150 | 82 | 4 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 150 | 82 | 4 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.74e-04 | 151 | 82 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.02e-04 | 157 | 82 | 4 | 5fb41af247465aa29aa7b8edd26e3d3794766f80 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 158 | 82 | 4 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.12e-04 | 159 | 82 | 4 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.12e-04 | 159 | 82 | 4 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 163 | 82 | 4 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 163 | 82 | 4 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.39e-04 | 164 | 82 | 4 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.39e-04 | 164 | 82 | 4 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Ciliated_cells-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-04 | 165 | 82 | 4 | 0ebdbbdb151fb797335013d5838af1c7bbc45b06 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.74e-04 | 170 | 82 | 4 | d6e244725b21592c6056b9c443aac090f1eae836 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.86e-04 | 172 | 82 | 4 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 2.86e-04 | 172 | 82 | 4 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 175 | 82 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-04 | 177 | 82 | 4 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | droplet-Marrow|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-04 | 177 | 82 | 4 | 0b8a1496c078874def0bfca0268136f1a84b82fd | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.26e-04 | 178 | 82 | 4 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-04 | 178 | 82 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-04 | 179 | 82 | 4 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 3.33e-04 | 179 | 82 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-04 | 179 | 82 | 4 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-04 | 180 | 82 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.40e-04 | 180 | 82 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-04 | 182 | 82 | 4 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.54e-04 | 182 | 82 | 4 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-04 | 182 | 82 | 4 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 3.62e-04 | 183 | 82 | 4 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 183 | 82 | 4 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 183 | 82 | 4 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-04 | 184 | 82 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.77e-04 | 185 | 82 | 4 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.77e-04 | 185 | 82 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.85e-04 | 186 | 82 | 4 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.85e-04 | 186 | 82 | 4 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.85e-04 | 186 | 82 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.92e-04 | 187 | 82 | 4 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 3.92e-04 | 187 | 82 | 4 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.92e-04 | 187 | 82 | 4 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.92e-04 | 187 | 82 | 4 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.92e-04 | 187 | 82 | 4 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 188 | 82 | 4 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.00e-04 | 188 | 82 | 4 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 4.00e-04 | 188 | 82 | 4 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.00e-04 | 188 | 82 | 4 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.00e-04 | 188 | 82 | 4 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-04 | 188 | 82 | 4 | b6aad90fa77fbaf80487a55415aa6c245f2d1f7e | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.00e-04 | 188 | 82 | 4 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.00e-04 | 188 | 82 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| Drug | chelerythrine | 2.08e-06 | 357 | 73 | 9 | CID000002703 | |
| Drug | NSC-107146 | 1.01e-05 | 2 | 73 | 2 | CID000267616 | |
| Drug | 3'-fluoroaminopterin | 1.01e-05 | 2 | 73 | 2 | CID000128780 | |
| Drug | DIVEMA-MTX | 1.01e-05 | 2 | 73 | 2 | CID000430857 | |
| Drug | gamma-tBAMT | 1.01e-05 | 2 | 73 | 2 | CID000125341 | |
| Drug | 4-ethylacetophenone | 1.01e-05 | 2 | 73 | 2 | CID000013642 | |
| Drug | aditoprim | 1.01e-05 | 2 | 73 | 2 | CID000068755 | |
| Drug | 2,4-diamino-5-benzylpyrimidine | 1.01e-05 | 2 | 73 | 2 | CID000081752 | |
| Drug | 2,4-diamino-5-phenylpyrimidine | 1.01e-05 | 2 | 73 | 2 | CID000134761 | |
| Drug | methotrexate-alpha-aspartate | 1.01e-05 | 2 | 73 | 2 | CID000100376 | |
| Drug | ethyl isocyanatoacetate | 1.01e-05 | 2 | 73 | 2 | CID000076283 | |
| Drug | clinoptilolite | 2.95e-05 | 19 | 73 | 3 | CID006336554 | |
| Drug | 2,4,5,6-Tetraaminopyrimidine sulfate | 3.04e-05 | 3 | 73 | 2 | CID000070487 | |
| Drug | GNF-Pf-26 | 3.04e-05 | 3 | 73 | 2 | CID000093114 | |
| Drug | diaveridine | 3.04e-05 | 3 | 73 | 2 | CID000021453 | |
| Drug | I--254 | 3.04e-05 | 3 | 73 | 2 | CID000032285 | |
| Drug | 8-deazahomofolic acid | 3.04e-05 | 3 | 73 | 2 | CID000130665 | |
| Drug | chloroformamidine hydrochloride | 3.04e-05 | 3 | 73 | 2 | CID003084509 | |
| Drug | chloromethyl pivalate | 3.04e-05 | 3 | 73 | 2 | CID000087885 | |
| Drug | DMDP derivative | 3.04e-05 | 3 | 73 | 2 | CID000482165 | |
| Drug | MTX-gamma-DMPE | 3.04e-05 | 3 | 73 | 2 | CID000146936 | |
| Drug | dihydropteroylhexaglutamate | 3.04e-05 | 3 | 73 | 2 | CID000193840 | |
| Drug | F2Glu | 3.04e-05 | 3 | 73 | 2 | CID000125424 | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.75e-05 | 194 | 73 | 6 | 3288_UP | |
| Drug | phosphotyrosine (pY | 4.83e-05 | 203 | 73 | 6 | CID000030819 | |
| Drug | ethyl 4-acetylbenzoate | 6.06e-05 | 4 | 73 | 2 | CID000600911 | |
| Drug | pY490 | 6.06e-05 | 4 | 73 | 2 | CID000283017 | |
| Drug | K 130 | 6.06e-05 | 4 | 73 | 2 | CID000467834 | |
| Drug | 5-deazaaminopterin | 6.06e-05 | 4 | 73 | 2 | CID000097272 | |
| Drug | 2,4-diamino-6-nitroquinazoline | 6.06e-05 | 4 | 73 | 2 | CID000252163 | |
| Drug | AC1MQVYC | 6.06e-05 | 4 | 73 | 2 | CID003483303 | |
| Drug | methasquin | 6.06e-05 | 4 | 73 | 2 | CID000029335 | |
| Drug | pergularinine | 6.06e-05 | 4 | 73 | 2 | CID000264751 | |
| Drug | 5,8-dideazafolic acid | 6.06e-05 | 4 | 73 | 2 | CID003080619 | |
| Drug | dpGp | 6.06e-05 | 4 | 73 | 2 | CID000129100 | |
| Drug | 2-desamino-2-methylaminopterin | 1.01e-04 | 5 | 73 | 2 | CID000164085 | |
| Drug | tylophorinidine | 1.01e-04 | 5 | 73 | 2 | CID000161749 | |
| Drug | deoxytubulosine | 1.01e-04 | 5 | 73 | 2 | CID000165003 | |
| Drug | piritrexim isethionate | 1.01e-04 | 5 | 73 | 2 | CID000054368 | |
| Drug | chlorasquin | 1.01e-04 | 5 | 73 | 2 | CID000029336 | |
| Drug | methylbenzoprim | 1.01e-04 | 5 | 73 | 2 | CID000072438 | |
| Drug | ethyl cyanoacrylate | 1.51e-04 | 6 | 73 | 2 | CID000081530 | |
| Drug | NBMPR-P | 1.51e-04 | 6 | 73 | 2 | CID006335125 | |
| Drug | 4-thio-5-fluoro-dUMP | 1.51e-04 | 6 | 73 | 2 | CID003035986 | |
| Drug | 11-deazahomofolic acid | 1.51e-04 | 6 | 73 | 2 | CID000128960 | |
| Drug | 10-methyl-11-deazahomofolic acid | 1.51e-04 | 6 | 73 | 2 | CID000128963 | |
| Drug | R,S)-AMPA | 2.09e-04 | 36 | 73 | 3 | CID000001221 | |
| Drug | methylbenzylamine | 2.11e-04 | 7 | 73 | 2 | CID000007669 | |
| Drug | IAHQ | 2.11e-04 | 7 | 73 | 2 | CID000073009 | |
| Drug | 5-deazafolate | 2.11e-04 | 7 | 73 | 2 | CID000100150 | |
| Disease | thalamus volume | 6.67e-05 | 85 | 75 | 4 | EFO_0006935 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.77e-04 | 8 | 75 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Cannabis Abuse | 2.83e-04 | 10 | 75 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.83e-04 | 10 | 75 | 2 | C0236735 | |
| Disease | Hashish Abuse | 2.83e-04 | 10 | 75 | 2 | C0018614 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 5.69e-04 | 14 | 75 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 7.48e-04 | 16 | 75 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | vitamin C measurement | 7.48e-04 | 16 | 75 | 2 | EFO_0600003 | |
| Disease | Cannabis Dependence | 8.46e-04 | 17 | 75 | 2 | C0006870 | |
| Disease | Psychoses, Substance-Induced | 8.46e-04 | 17 | 75 | 2 | C0033941 | |
| Disease | uric acid measurement | 9.18e-04 | 610 | 75 | 7 | EFO_0004761 | |
| Disease | diet measurement, HOMA-B | 1.06e-03 | 19 | 75 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | brain age measurement | 1.18e-03 | 20 | 75 | 2 | EFO_0010602 | |
| Disease | body surface area | 1.24e-03 | 643 | 75 | 7 | EFO_0022196 | |
| Disease | Psychoses, Drug | 1.30e-03 | 21 | 75 | 2 | C0033937 | |
| Disease | thyroid stimulating hormone measurement | 1.41e-03 | 323 | 75 | 5 | EFO_0004748 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 1.42e-03 | 22 | 75 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | childhood aggressive behaviour measurement | 1.53e-03 | 89 | 75 | 3 | EFO_0007663 | |
| Disease | urate measurement | 1.95e-03 | 895 | 75 | 8 | EFO_0004531 | |
| Disease | Pancytopenia | 1.99e-03 | 26 | 75 | 2 | C0030312 | |
| Disease | Cholangiocarcinoma | 1.99e-03 | 26 | 75 | 2 | C0206698 | |
| Disease | lifestyle measurement, depressive symptom measurement | 2.45e-03 | 105 | 75 | 3 | EFO_0007006, EFO_0010724 | |
| Disease | resistin measurement | 2.48e-03 | 29 | 75 | 2 | EFO_0004819 | |
| Disease | osteoarthritis | 2.50e-03 | 222 | 75 | 4 | MONDO_0005178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYFDEEFTAQMITIT | 436 | P31749 | |
| SATVFMSEVTNEAVY | 396 | Q9Y6Y1 | |
| MEVTVESSVLTSFYN | 116 | Q9UJX5 | |
| RSTLQTMESDIYTEV | 311 | Q07065 | |
| TTYVVSASISDDMFI | 2646 | Q8IZF6 | |
| VTSSDYRVQTTTMCI | 791 | Q14832 | |
| YQSFAVTMATSLVIV | 991 | Q8TF62 | |
| QENISFETMYDVLST | 346 | Q13510 | |
| QASFFVVYNMVTTEV | 361 | Q7L5Y6 | |
| AVTEQSYMESVVTFL | 26 | Q9H6U6 | |
| TYATVEEVDAAMNTT | 61 | Q32P51 | |
| VTDGMRESFTVYESQ | 561 | Q9NYA3 | |
| IAYVSREMLVTNTQT | 781 | P26045 | |
| IFEYAESVTSTAMTS | 676 | Q9HCL0 | |
| MAERNYTVVTEFFLT | 1 | Q8NGE9 | |
| YFNVTTDITASAMRV | 1086 | Q8IY17 | |
| YVSSTTGESVITREM | 71 | O60684 | |
| FTVVIFSMQTRYDFT | 266 | Q7Z429 | |
| SRQTMFYTEVTDAQR | 151 | O95848 | |
| DSVDVMVFIVTSYSI | 36 | P50391 | |
| SEAQDMTYTAFSDVV | 236 | Q9ULD2 | |
| DTYTVQISPMSAFVE | 1321 | Q76N89 | |
| VESYLQMEDVTSTFI | 781 | Q8IYD8 | |
| RDQFTTTEVNMARVY | 166 | P61758 | |
| QMVYIVTEDTDDFTR | 151 | Q9NRQ2 | |
| SFSQVLEETYMLAVT | 131 | O94830 | |
| DETMVRIFSSIVAFY | 2036 | Q6ZR08 | |
| FTYNETMTVESVTQA | 101 | P28066 | |
| RVTITADTSTDTAYM | 86 | A0A0G2JMI3 | |
| MSIINTSYVEITTFF | 1 | Q8NGJ7 | |
| MSIINTSYVEITTFF | 1 | Q8NGJ6 | |
| VTDGMRESFTVYESQ | 561 | A6NDN3 | |
| RVTITADESTSTAYM | 86 | A0A0B4J2H0 | |
| TIYSTSVTDSKAMQV | 91 | O94916 | |
| TSVRAYMTVLQSIEN | 741 | Q9Y2A7 | |
| FDFTATQEMVYQATT | 71 | Q2TAC6 | |
| ESSRITAVASVMYTV | 266 | Q8NGA0 | |
| YNVSTSTRTVMVEEF | 326 | Q9BWT3 | |
| SVDYSSVVVAAMQAR | 86 | P0DPD8 | |
| ITDNAYTSSQIREME | 236 | O95067 | |
| KRQEFYVSRMETSTV | 1426 | Q99715 | |
| TTVNEMSRVYLATER | 2996 | Q9UFH2 | |
| QMETTQSLVDSYVAI | 31 | Q6PK57 | |
| DISDSDVQQFRVTYM | 756 | Q05707 | |
| EFRYFQRMTTTSSVE | 31 | P00374 | |
| FYNFTVMESDRVTEI | 1366 | Q8TDW7 | |
| NTIMEQYTRTEESAR | 706 | Q9BYX4 | |
| VTDGMRESFTVYESQ | 561 | A6NDK9 | |
| TSILFMVSSSEYDQV | 246 | Q03113 | |
| VTAIIFVVASSSYNM | 241 | P63092 | |
| FVVASSSYNMVIRED | 246 | P63092 | |
| TDSTTEVIYEAMRQV | 506 | Q8NEU8 | |
| VNVYSTSITQETMSR | 46 | Q15555 | |
| EFRYFQRMTTTSSVE | 31 | Q86XF0 | |
| VTDGMRESFTVYESQ | 561 | P0CG33 | |
| FFSTDEITTRYRNTM | 16 | Q86Z14 | |
| EMVIALQNTTTTSRY | 391 | Q9Y238 | |
| ITRDSIMNYFRTESE | 171 | Q9UKG9 | |
| NSQSVKVSFSVTYEM | 501 | Q5HYA8 | |
| TSTFTLTAMSVDRYV | 136 | P41146 | |
| TSVVAMAKTYATTEA | 271 | O14994 | |
| MATTVTCTRFTDEYQ | 1 | Q13554 | |
| VMTVRDFTQVFDSYA | 286 | Q9HCS7 | |
| NISEQSATTVRYTMK | 326 | P48764 | |
| TTTEMPFTTSVFQIY | 491 | Q8N695 | |
| TESVSTDTIYAMSVF | 141 | Q92535 | |
| SVDYSSVVVAAMQAR | 86 | P0DPD7 | |
| VTSVITTEVDMRYYN | 416 | Q6Q759 | |
| QIEDMVTTASTYLFE | 51 | Q14CN2 | |
| MSEEVTYATLTFQDS | 1 | Q2HXU8 | |
| SYVFENTVATVMALR | 496 | P49588 | |
| TYFITNTTTQENKRM | 191 | Q6ZVD7 | |
| AFIDIFTSNTYVMVV | 261 | Q7L523 | |
| TVYSTSDRSVIERDM | 606 | O95171 | |
| RTMVSTRFQKENYTT | 681 | Q9NYB5 | |
| DSVDVMVFIVTSYSI | 36 | P0DQD5 | |
| VVFSDVNSMYLSSTE | 311 | A7E2V4 | |
| LTSQNAIEVMTVASY | 431 | Q96DT7 | |
| TAAQVVTQAMEYVRS | 481 | O94900 | |
| KTYLEVVRSVFMSST | 511 | O94874 | |
| AAVTVFVSMIASRSY | 16 | Q6ZT21 | |
| SSTLYDVAMEAVTQS | 91 | O75132 | |
| RETTNMKTQTVASYF | 916 | Q8NEV4 | |
| EETTNMKRQTVASYF | 921 | Q8WXR4 |